Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
Parkinson’s disease (PD) is a common age-associated neurodegenerative motor disorder, which is mainly caused by dopaminergic neuron loss in the substantia nigra. This study aimed to evaluate the function and the underlying molecular mechanism of itaconate in PD. PD models were established in vivo an...
Main Authors: | Guoqing Sun, Rui Zhang, Chengxiao Liu, Wenjun Meng, Qi Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/9/1255 |
Similar Items
-
Itaconate Suppresses the Activation of Mitochondrial NLRP3 Inflammasome and Oxidative Stress in Allergic Airway Inflammation
by: Qiu-Meng Xie, et al.
Published: (2023-02-01) -
Itaconate confers tolerance to late NLRP3 inflammasome activation
by: Monika Bambouskova, et al.
Published: (2021-03-01) -
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
by: Liang Kou, et al.
Published: (2022-06-01) -
Dimethyl Itaconate Attenuates CFA-Induced Inflammatory Pain via the NLRP3/ IL-1β Signaling Pathway
by: Jiaqi Lin, et al.
Published: (2022-07-01) -
Metabolite itaconate in host immunoregulation and defense
by: Wenchang Yang, et al.
Published: (2023-12-01)